Intas Pharmaceuticals
- All
- News
-
Teva To Sell Allergan's Generics Business In UK, Ireland To Intas Pharmaceuticals
Greenhill & Co is Teva's financial adviser, while Rothschild & Co is advising Intas Pharmaceuticals.
-
Aurobindo Pharma Gains On Buzz Of Big UK Acquisition
Aurobindo Pharma shares gained over 1 per cent on Monday after a news report said that the Indian pharma company is a frontrunner to buy Teva Pharmaceutical's UK business, which had revenue of around $300 million last fiscal.
-
RPG Life Sells Gujarat Biotech Unit To Intas Pharma
RPG Life Sciences has sold its Gujarat-based biotechnology unit to Intas Pharmaceuticals for Rs 25 crore to focus on core areas of business and improve long-term competitiveness in a rapidly changing market.
-
Intas Pharma Expects US Approval for White Blood Cell Drug This Year
Intas Pharmaceuticals Ltd could get approval this year to launch a version of Amgen Inc's white blood cell boosting Neulasta drug in the United States, chief financial officer Jayesh Shah said.
-
Temasek Completes 10.16 Per Cent Stake Purchase in Intas Pharma
Temasek Holding, investment arm of the Singapore government, has completed the acquisition of a 10.16 per cent stake in Intas Pharmaceuticals.
-
Fair Trade Regulator Approves 10.16 Per Cent Stake Buy in Intas by Temasek
The Competition Commission of India (CCI) has cleared Singapore government investment arm Temasek Holding's proposed acquisition of a 10.16 per cent stake in Intas Pharmaceuticals, saying the deal will not raise anti-competition concerns.
-
Teva To Sell Allergan's Generics Business In UK, Ireland To Intas Pharmaceuticals
Greenhill & Co is Teva's financial adviser, while Rothschild & Co is advising Intas Pharmaceuticals.
-
Aurobindo Pharma Gains On Buzz Of Big UK Acquisition
Aurobindo Pharma shares gained over 1 per cent on Monday after a news report said that the Indian pharma company is a frontrunner to buy Teva Pharmaceutical's UK business, which had revenue of around $300 million last fiscal.
-
RPG Life Sells Gujarat Biotech Unit To Intas Pharma
RPG Life Sciences has sold its Gujarat-based biotechnology unit to Intas Pharmaceuticals for Rs 25 crore to focus on core areas of business and improve long-term competitiveness in a rapidly changing market.
-
Intas Pharma Expects US Approval for White Blood Cell Drug This Year
Intas Pharmaceuticals Ltd could get approval this year to launch a version of Amgen Inc's white blood cell boosting Neulasta drug in the United States, chief financial officer Jayesh Shah said.
-
Temasek Completes 10.16 Per Cent Stake Purchase in Intas Pharma
Temasek Holding, investment arm of the Singapore government, has completed the acquisition of a 10.16 per cent stake in Intas Pharmaceuticals.
-
Fair Trade Regulator Approves 10.16 Per Cent Stake Buy in Intas by Temasek
The Competition Commission of India (CCI) has cleared Singapore government investment arm Temasek Holding's proposed acquisition of a 10.16 per cent stake in Intas Pharmaceuticals, saying the deal will not raise anti-competition concerns.
